BIOSENSORS International Group Ltd on Friday said its wholly
owned Biosensors Investment (Singapore) Pte Ltd has set up an S$800
million Multicurrency Medium-Term Note (MTN) programme to raise funds
through note issuances.
The medical devices maker said the net proceeds from the note issues may be used to "fund new business opportunities, refinance existing borrowings and finance investments (including capital expenditure) and working capital requirements of companies within the Biosensors group."
It added that it has received in-principle approval from the Singapore Exchange to list the notes issued under the programme.
Each series of notes may be issued in Singapore dollars or in other currencies, amounts and maturities, and may comprise notes with fixed, floating or variable interest rates, it said.
The medical devices maker said the net proceeds from the note issues may be used to "fund new business opportunities, refinance existing borrowings and finance investments (including capital expenditure) and working capital requirements of companies within the Biosensors group."
It added that it has received in-principle approval from the Singapore Exchange to list the notes issued under the programme.
Each series of notes may be issued in Singapore dollars or in other currencies, amounts and maturities, and may comprise notes with fixed, floating or variable interest rates, it said.
Posts
No comments:
Post a Comment